according to a may 25, 2018 "cnbc" article, rudolph w. giuliani, who was representing purdue pharma as lead counsel and lead spokesmen during their 2006-2007 negotiations with federal prosecutors over charges that the purdue had misled the public about oxycontin's addictive properties, held meetings with alice s. fisher who was head of the united states assistant attorney general for the criminal division from 2005 to 2008. following these meetings, fisher "chose not to pursue indictments against purdue pharma for their role in opioid abuse".